Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001405253-26-000005

See Remarks acquired 13,042 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Farrow Jeffrey S See Remarks 2026-03-15 Option exercise +13,042 49,746 D
Derivatives
Farrow Jeffrey S See Remarks 2026-03-15 Option exercise · Restricted Stock Units −8,020 16,040 D
Farrow Jeffrey S See Remarks 2026-03-15 Option exercise · Restricted Stock Units −5,022 15,067 D
Loading xslF345X05/wk-form4_1773779217.xml…